Developer docs
API playgroundTry for free, no card

Search company profiles

Stanford School of Medicine

Full company profile

uuid0008289

Namestring
Stanford School of Medicine
Legal namestring
Stanford University School of Medicine
Company typeenum
Private
Founded yearint
1908
Descriptiontext

Stanford School of Medicine (Stanford Medicine), founded in 1908 and headquartered in Stanford, California, is the academic medical center of Stanford University. It integrates biomedical research, medical education, and clinical care through three entities: the School of Medicine, Stanford Health Care (adult care), and Lucile Packard Children's Hospital Stanford (pediatric and maternal care). The institution educates approximately 1,500 medical and graduate students (382 MD, 100 MD/PhD, 844 PhD, 205 MS candidates), supports 1,276 postdoctoral scholars and 1,257 residents/clinical fellows, and maintains 184 full-time basic science faculty.

Stanford Medicine's research portfolio spans proprietary AI foundation models including SleepFM (trained on 585,000 hours of sleep recordings from 65,000 participants, predicting 130+ health conditions), Merlin AI (3D abdominal CT scan analysis trained on 15,000+ scans), and CRISPR-GPT (open-source gene-editing design tool). The institution operates advanced clinical infrastructure including a new $33 million Mevion S250-FIT proton therapy system and the world's first compact upright proton therapy platform (Leo Cancer Care Marie). Faculty credentials include 8 Nobel laureates, 58 National Academy of Sciences members, 46 National Academy of Medicine members, and 11 Howard Hughes Medical Institute investigators, yielding the highest NIH funding per researcher ratio in the United States.

Revenue is generated through four streams: federal and NIH research grants, clinical care delivery through the hospital network, tuition and continuing medical education, and licensing/royalty income from research discoveries (e.g., Simcere pharmaceutical partnership). The institution does not publicly disclose medical school-level financials; Stanford University's consolidated FY2024 operating revenue was approximately $7.2 billion. Go-to-market is primarily relationship-driven through long-term industry partnerships (GE HealthCare, NVIDIA, OpenAI, Google DeepMind, Samsung), clinical trial enrollment, academic program admissions, and technology licensing rather than traditional sales channels.

Short descriptiontext

Stanford School of Medicine is an academic medical center founded in 1908, integrating biomedical research, medical education, and clinical care through Stanford Health Care and Lucile Packard Children's Hospital, serving patients, trainees, and industry research partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersStanford, United States
HQ citystring
Stanford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical education, biomedical research, clinical care, academic medicine, physician training
Industry5 codes
1Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryYes
2Academic Medical Centers (AMCs) & Teaching Hospitals
CodeHLAFAAAAPrimaryNo
3Medical Schools (MD/DO Granting)
CodeEDAHAGABPrimaryNo
4Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryNo
5Public Research Universities with Academic Medical Centers (AMCs)
CodeEDAHAAACPrimaryNo
NAICS code4 codes
  • General Medical and Surgical Hospitals6221
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories62151
  • Scientific Research and Development Services5417
SIC code4 codes
  • Services-Hospitals8060
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Services-Health Services8000
Product category
Academic Medical Center
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Research Funding and Grants
TypeSubscription Recurring
Description

Primary revenue from NIH and other research funding, including NIH Director's Pioneer Awards, with the highest funding per researcher ratio in the country.

med.stanford.edu:443
2Clinical Care Services
TypeSubscription Recurring
Description

Revenue from patient care services through Stanford Health Care and Lucile Packard Children's Hospital Stanford.

med.stanford.edu:443
3Education and Training
TypeSubscription Recurring
Description

Tuition and fees from MD, PhD, MS programs and continuing medical education offerings.

med.stanford.edu:443
4Licensing and Royalties
TypeLicensing Royalties
Description

Revenue from licensing novel molecules and technologies developed through research collaborations, such as Simcere pharmaceutical partnership.

prnewswire.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Stanford Medicine operates an integrated academic health system that educates physicians and scientists through MD, MD/PhD, PhD, MS, residency, fellowship, and continuing medical education programs; conducts biomedical research across basic and clinical science departments supported by NIH and other grants; and delivers patient care through Stanford Health Care (adult) and Lucile Packard Children's Hospital Stanford (pediatric and maternal). It also licenses discoveries and runs clinical trials in collaboration with pharmaceutical, biotechnology, and technology partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • SleepFM achieves C-index >0.8 for predicting Parkinson's disease (0.89), prostate cancer (0.89), breast cancer (0.87), heart attack (0.81), and death (0.84)
+5 more records
Product overview1 text field

Stanford School of Medicine operates as an integrated academic health system comprising the Stanford School of Medicine, Stanford Health Care, and Lucile Packard Children's Hospital Stanford. The institution offers a broad portfolio of medical products and services including clinical care delivery across multiple specialties, advanced medical technologies (proton therapy systems, wearable monitoring devices), AI-powered diagnostic tools (SleepFM for disease prediction from sleep data, Merlin for CT scan analysis, CRISPR-GPT for gene editing assistance), and innovative therapeutic approaches (obexelimab for immune disorders, CNTF implants for glaucoma, LRRK2 inhibitors for Parkinson's). Stanford Medicine also provides medical education programs, maintains extensive clinical trial operations, and licenses research discoveries for commercial development.

Product and service12 records
1Stanford Health Care Clinical Services
CategoryClinical care services
2Lucile Packard Children's Hospital Stanford (Stanford Children's Health)
CategoryPediatric and maternal clinical care
3MD Program
CategoryMedical education
4PhD Programs (Biosciences)
CategoryGraduate education
5Master's Programs
CategoryGraduate education
6Continuing Medical Education
CategoryProfessional medical education
7Postdoctoral Training and Residencies/Fellowships
CategoryPostdoctoral and graduate medical training
8Clinical Trials Program
CategoryClinical research services
9Research Collaboration and Technology Licensing
CategoryResearch collaboration and licensing
10SleepFM AI Foundation Model
CategoryAI diagnostic tool
11Merlin AI Diagnostic Model
CategoryAI diagnostic tool
12CRISPR-GPT
CategoryAI research tool
Scale indicator20 records

Each record includes

Type, Value, Description, Source

Partnership26 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-18
Description

Mevion S250-FIT Proton Therapy System installed at Stanford Medicine for $33 million. This compact proton therapy system represents technological breakthrough, reducing system size from three-story building to single room, making treatment more accessible to Bay Area patients.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-09
Description

World's first compact upright proton therapy treatment using Leo Cancer Care's Marie platform integrated with Stanford's Mevion system. The technology reduces space required for proton therapy by over 90%, enabling installation within existing radiotherapy vaults.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-04
Description

Sponsor of obexelimab clinical trial for IgG4-related disease; Stanford Medicine co-led the international trial published in NEJM showing 50% reduction in relapse risk.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-29
Description

Research collaboration agreement to jointly conduct exploratory study developing innovative therapies for patients with idiopathic pulmonary fibrosis. Simcere will fund exploratory research on a first-in-class novel molecule and, upon successful completion, will license it and acquire 100% of global rights. This is the second first-in-class original project in the Simcere-Stanford partnership, aligned with Simcere's 'Innovation 2.0' strategy.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-28
Description

Co-host of Food is Life, Food is Health summit with Stanford Medicine, Harvard T.H. Chan School of Public Health, and Stanford Doerr School of Sustainability, bringing together medical professionals, chefs, and nutrition scientists.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-28
Description

Co-host of Food is Life, Food is Health summit exploring how culinary skill and evidence-based research can advance human and planetary health.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-26
Description

Collaboration on comprehensive risk assessment of AI therapy apps, with Stanford Medicine's Brainstorm Lab reviewing over 3,100 exchanges with five AI therapy apps.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

First U.S. clinical trial (SUNRISE-II) of ultrasound-guided HIFU therapy for pancreatic cancer, with first patient treated at Stanford Medicine in March 2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

AI co-clinician research initiative to explore triadic care model where AI assists doctors and patients. In simulations with Stanford Medicine and Harvard Medical School, the system achieved zero critical errors in 97 of 98 primary care queries.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-15
Description

Strategic collaboration with NVIDIA for XR and AI integration in healthcare applications. VITURE partnership disclosure mentions collaboration with NVIDIA and Stanford University School of Medicine to advance XR and AI integration in healthcare.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-10
Description

Collaboration on AI applications for sleep apnea detection and health prediction, advancing sleep medicine research and technology development.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-10
Description

Samsung integration of sleep apnea risk detection into Galaxy Watch devices, with Stanford Medicine advancing AI applications for sleep apnea detection.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-10
Description

Microsoft launching AI-powered health tools, with Stanford Medicine advancing AI applications for sleep medicine and health prediction.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-30
Description

Renewed research collaboration with Stanford Medicine Department of Radiology to establish a Center of Excellence focused on advanced imaging research across magnetic resonance, computed tomography, molecular imaging, AI, and interventional radiology. The collaboration builds on over 40 years of partnership that has produced 153 funded research projects, 184 peer-reviewed manuscripts, and 66 licensed patents.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-26
Description

Partnership in CRI Discovery Engine initiative for standardized cancer immunotherapy research data infrastructure, alongside Stanford University School of Medicine, UPenn, and Memorial Sloan Kettering.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-20
Description

DiMe launched standardized digital clinical measures for pediatric rare disease in collaboration with FDA, BioMarin, Northwestern Medicine, and Stanford Medicine.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-20
Description

Collaboration under LANTERN project for lymphatic disease diagnostic toolbox development, contributing detection technologies and patient database analysis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-09
Description

Multi-stakeholder initiative 'Scaling Trusted, High-Impact AI Care Navigation' to accelerate responsible AI adoption for patient care management. Stanford Medicine is a founding coalition member alongside Google for Health, Mass General Brigham, and others.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-08
Description

Stanford Medicine is an early adopter of OpenAI's HIPAA-compliant healthcare AI suite including ChatGPT for Healthcare and OpenAI API products designed for healthcare organizations requiring compliance with US patient privacy regulations.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-11-27
Description

15-PGDH inhibitor (originally discovered at Stanford) in clinical trials for age-related muscle weakness. Stanford research showed blocking this protein regenerates joint cartilage.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-06
Description

Up to $18 million in CEPI funding for Stanford School of Medicine researchers to design AI-powered vaccine constructs using ferritin-based nanoparticle platform for broad protection against filoviruses including Ebola and Marburg.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-09-26
Description

Collaborative study on skin-to-skin contact associated with brain changes in preterm infants, conducted with Burke Neurological Institute and Stanford Medicine.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-07-09
Description

Research partnership with Stanford Medicine for AI health coaching research focused on sleep, nutrition, fitness, stress management, and social connection to address chronic diseases.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-06-01
Description

Clinical collaboration with Stanford Medicine's Psychiatry and Behavioral Sciences Department for controlled study enrolling at least 210 depressed patients using Matter protocol combined with real-time 7T fMRI neurofeedback.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-04-01
Description

Partnership to enhance sleep apnea management capabilities of Samsung's Galaxy Watch from detection to daily condition management. Stanford Medicine contributing research expertise for sleep apnea AI development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Historical collaboration on Apple Heart Study that enrolled over 400,000 participants and led to FDA-cleared ECG feature on Apple Watch. Stanford pioneered research model using consumer wearables with clinical research through opt-in data collection.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Johns Hopkins School of Medicine is a leading US academic medical center with comparable NIH funding, Nobel laureate faculty, and integrated hospital system (Johns Hopkins Hospital). It competes directly with Stanford for research talent, NIH grants, and top medical student candidates.

TypeDirect peer
Description

Yale School of Medicine is a top-tier peer AMC with similar research-education-clinical care structure, comparable NIH funding profile, and direct competition for biomedical research faculty.

TypeBroad incumbent
Description

Mayo Clinic is a peer integrated academic health system with national reach, comparable clinical excellence, and growing research footprint. Mayo also has a sleep apnea AI collaboration with Stanford. Functions as a broader clinical enterprise rather than Stanford's more research-centric model.

TypeDirect peer
Description

Duke School of Medicine is a peer top-tier US medical school with comparable NIH funding, integrated health system, and similar AI/biomedical research initiatives competing for federal grants and industry partnerships.

TypeDirect peer
Description

Harvard Medical School is the most direct peer to Stanford School of Medicine as a top-tier US medical school affiliated with multiple teaching hospitals (Mass General Brigham), with similar tripartite research-education-clinical care mission, comparable NIH funding levels, and overlapping faculty recruitment pools.

TypeDirect peer
Description

Washington University School of Medicine is a top NIH-funded medical school with comparable research output per faculty member, similar biotech partnership model, and competing for the same faculty and trainee talent.

TypeDirect peer
Description

UCSF School of Medicine is a top public medical school located in San Francisco with high NIH funding per researcher, similar biotech partnership ecosystem, and overlapping Bay Area patient populations. Competes with Stanford for regional faculty, students, and clinical referrals.

TypeDirect peer
Description

Penn's Perelman School of Medicine is a peer top-tier AMC with comparable NIH funding, integrated health system, and AI/biomedical research initiatives. It is also a partner in the Cancer Research Institute Discovery Engine initiative alongside Stanford.

TypeDirect peer
Description

Columbia's medical school is a peer Ivy League AMC with similar tripartite mission, comparable research funding levels, and overlapping recruitment markets for biomedical research faculty.

TypeDirect peer
Description

Weill Cornell Medicine is a peer NYC-based AMC and active research collaborator with Stanford (e.g., Burke Neurological Institute preterm infant study). Comparable in research output, faculty credentials, and integrated hospital system structure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers20 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability15 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Stanford School of Medicine

Academic Medical Centermed.stanford.edu

Stanford School of Medicine is an academic medical center founded in 1908, integrating biomedical research, medical education, and clinical care through Stanford Health Care and Lucile Packard Children's Hospital, serving patients, trainees, and industry research partners.

What Stanford School of Medicine does

Stanford School of Medicine (Stanford Medicine), founded in 1908 and headquartered in Stanford, California, is the academic medical center of Stanford University. It integrates biomedical research, medical education, and clinical care through three entities: the School of Medicine, Stanford Health Care (adult care), and Lucile Packard Children's Hospital Stanford (pediatric and maternal care). The institution educates approximately 1,500 medical and graduate students (382 MD, 100 MD/PhD, 844 PhD, 205 MS candidates), supports 1,276 postdoctoral scholars and 1,257 residents/clinical fellows, and maintains 184 full-time basic science faculty.

Stanford Medicine's research portfolio spans proprietary AI foundation models including SleepFM (trained on 585,000 hours of sleep recordings from 65,000 participants, predicting 130+ health conditions), Merlin AI (3D abdominal CT scan analysis trained on 15,000+ scans), and CRISPR-GPT (open-source gene-editing design tool). The institution operates advanced clinical infrastructure including a new $33 million Mevion S250-FIT proton therapy system and the world's first compact upright proton therapy platform (Leo Cancer Care Marie). Faculty credentials include 8 Nobel laureates, 58 National Academy of Sciences members, 46 National Academy of Medicine members, and 11 Howard Hughes Medical Institute investigators, yielding the highest NIH funding per researcher ratio in the United States.

Revenue is generated through four streams: federal and NIH research grants, clinical care delivery through the hospital network, tuition and continuing medical education, and licensing/royalty income from research discoveries (e.g., Simcere pharmaceutical partnership). The institution does not publicly disclose medical school-level financials; Stanford University's consolidated FY2024 operating revenue was approximately $7.2 billion. Go-to-market is primarily relationship-driven through long-term industry partnerships (GE HealthCare, NVIDIA, OpenAI, Google DeepMind, Samsung), clinical trial enrollment, academic program admissions, and technology licensing rather than traditional sales channels.

Stanford School of Medicine firmographics

Firmographics
Name
Stanford School of Medicine
Legal name
Stanford University School of Medicine
Website
https://med.stanford.edu
Company type
Private
Founded year
1908
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Stanford School of Medicine is an academic medical center founded in 1908, integrating biomedical research, medical education, and clinical care through Stanford Health Care and Lucile Packard Children's Hospital, serving patients, trainees, and industry research partners.
Ownership category
akta.pro rank

Stanford School of Medicine industry classification

Industry
Product category
Academic Medical Center
NAICS
General Medical and Surgical Hospitals (6221), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417)
SIC
Services-Hospitals (8060), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Health Services (8000)
akta.pro primary industry
Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)
akta.pro secondary industries
Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA), Medical Schools (MD/DO Granting) (EDAHAGAB), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

  • Medical education
  • Biomedical research
  • Clinical care
  • Academic medicine
  • Physician training

Where Stanford School of Medicine is headquartered

Location

Headquarters

HQ city
Stanford
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Stanford School of Medicine business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Research Funding and Grants: Primary revenue from NIH and other research funding, including NIH Director's Pioneer Awards, with the highest funding per researcher ratio in the country.
  2. Clinical Care Services: Revenue from patient care services through Stanford Health Care and Lucile Packard Children's Hospital Stanford.
  3. Education and Training: Tuition and fees from MD, PhD, MS programs and continuing medical education offerings.
  4. Licensing and Royalties: Revenue from licensing novel molecules and technologies developed through research collaborations, such as Simcere pharmaceutical partnership.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Stanford School of Medicine product offering

Product offering

Core offering

Stanford Medicine operates an integrated academic health system that educates physicians and scientists through MD, MD/PhD, PhD, MS, residency, fellowship, and continuing medical education programs; conducts biomedical research across basic and clinical science departments supported by NIH and other grants; and delivers patient care through Stanford Health Care (adult) and Lucile Packard Children's Hospital Stanford (pediatric and maternal). It also licenses discoveries and runs clinical trials in collaboration with pharmaceutical, biotechnology, and technology partners.

Product overview

Stanford School of Medicine operates as an integrated academic health system comprising the Stanford School of Medicine, Stanford Health Care, and Lucile Packard Children's Hospital Stanford. The institution offers a broad portfolio of medical products and services including clinical care delivery across multiple specialties, advanced medical technologies (proton therapy systems, wearable monitoring devices), AI-powered diagnostic tools (SleepFM for disease prediction from sleep data, Merlin for CT scan analysis, CRISPR-GPT for gene editing assistance), and innovative therapeutic approaches (obexelimab for immune disorders, CNTF implants for glaucoma, LRRK2 inhibitors for Parkinson's). Stanford Medicine also provides medical education programs, maintains extensive clinical trial operations, and licenses research discoveries for commercial development.

Differentiator

Problem solved

Functional benefit

Products and services

  • Stanford Health Care Clinical Services
  • Lucile Packard Children's Hospital Stanford (Stanford Children's Health)
  • MD Program
  • PhD Programs (Biosciences)
  • Master's Programs
  • Continuing Medical Education
  • Postdoctoral Training and Residencies/Fellowships
  • Clinical Trials Program
  • Research Collaboration and Technology Licensing
  • SleepFM AI Foundation Model
  • Merlin AI Diagnostic Model
  • CRISPR-GPT

Quantifiable outcome

  • SleepFM achieves C-index >0.8 for predicting Parkinson's disease (0.89), prostate cancer (0.89), breast cancer (0.87), heart attack (0.81), and death (0.84)
  • +5 more outcomes

Companies that use Stanford School of Medicine

Customer profile

Named customers20 records

Segments4 records

Ideal customer profiles4 records

Stanford School of Medicine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability15 records

Feature6 records

Stanford School of Medicine partnerships and signals

Strategic signal

Partnerships

26 partnerships are on record, tiered core and minor.

  • Mevion Medical SystemscoreTechnology or Integration · 18 June 2026Mevion S250-FIT Proton Therapy System installed at Stanford Medicine for $33 million. This compact proton therapy system represents technological breakthrough, reducing system size from three-story building to single room, making treatment more accessible to Bay Area patients.
  • Leo Cancer CarecoreTechnology or Integration · 9 June 2026World's first compact upright proton therapy treatment using Leo Cancer Care's Marie platform integrated with Stanford's Mevion system. The technology reduces space required for proton therapy by over 90%, enabling installation within existing radiotherapy vaults.
  • Zenas BioPharmacoreStrategic or Co-development Partner · 4 June 2026Sponsor of obexelimab clinical trial for IgG4-related disease; Stanford Medicine co-led the international trial published in NEJM showing 50% reduction in relapse risk.
  • Simcere Pharmaceutical GroupcoreStrategic or Co-development Partner · 29 May 2026Research collaboration agreement to jointly conduct exploratory study developing innovative therapies for patients with idiopathic pulmonary fibrosis. Simcere will fund exploratory research on a first-in-class novel molecule and, upon successful completion, will license it and acquire 100% of global rights. This is the second first-in-class original project in the Simcere-Stanford partnership, aligned with Simcere's 'Innovation 2.0' strategy.
  • Culinary Institute of AmericaminorStrategic or Co-development Partner · 28 May 2026Co-host of Food is Life, Food is Health summit with Stanford Medicine, Harvard T.H. Chan School of Public Health, and Stanford Doerr School of Sustainability, bringing together medical professionals, chefs, and nutrition scientists.
  • Harvard T.H. Chan School of Public HealthminorStrategic or Co-development Partner · 28 May 2026Co-host of Food is Life, Food is Health summit exploring how culinary skill and evidence-based research can advance human and planetary health.
  • Common Sense MediacoreStrategic or Co-development Partner · 26 May 2026Collaboration on comprehensive risk assessment of AI therapy apps, with Stanford Medicine's Brainstorm Lab reviewing over 3,100 exchanges with five AI therapy apps.
  • Sonire TherapeuticsminorStrategic or Co-development Partner · 1 May 2026First U.S. clinical trial (SUNRISE-II) of ultrasound-guided HIFU therapy for pancreatic cancer, with first patient treated at Stanford Medicine in March 2026.
  • Google DeepMindcoreStrategic or Co-development Partner · 30 April 2026AI co-clinician research initiative to explore triadic care model where AI assists doctors and patients. In simulations with Stanford Medicine and Harvard Medical School, the system achieved zero critical errors in 97 of 98 primary care queries.
  • NVIDIAcoreTechnology or Integration · 15 April 2026Strategic collaboration with NVIDIA for XR and AI integration in healthcare applications. VITURE partnership disclosure mentions collaboration with NVIDIA and Stanford University School of Medicine to advance XR and AI integration in healthcare.
  • Mayo CliniccoreStrategic or Co-development Partner · 10 April 2026Collaboration on AI applications for sleep apnea detection and health prediction, advancing sleep medicine research and technology development.
  • SamsungcoreTechnology or Integration · 10 April 2026Samsung integration of sleep apnea risk detection into Galaxy Watch devices, with Stanford Medicine advancing AI applications for sleep apnea detection.
  • MicrosoftcoreTechnology or Integration · 10 April 2026Microsoft launching AI-powered health tools, with Stanford Medicine advancing AI applications for sleep medicine and health prediction.
  • GE HealthCarecoreTechnology or Integration · 30 March 2026Renewed research collaboration with Stanford Medicine Department of Radiology to establish a Center of Excellence focused on advanced imaging research across magnetic resonance, computed tomography, molecular imaging, AI, and interventional radiology. The collaboration builds on over 40 years of partnership that has produced 153 funded research projects, 184 peer-reviewed manuscripts, and 66 licensed patents.
  • Cancer Research InstitutecoreStrategic or Co-development Partner · 26 February 2026Partnership in CRI Discovery Engine initiative for standardized cancer immunotherapy research data infrastructure, alongside Stanford University School of Medicine, UPenn, and Memorial Sloan Kettering.
  • Digital Medicine Society (DiMe)coreStrategic or Co-development Partner · 20 January 2026DiMe launched standardized digital clinical measures for pediatric rare disease in collaboration with FDA, BioMarin, Northwestern Medicine, and Stanford Medicine.
  • Memorial Sloan Kettering Cancer CenterminorStrategic or Co-development Partner · 20 January 2026Collaboration under LANTERN project for lymphatic disease diagnostic toolbox development, contributing detection technologies and patient database analysis.
  • Digital Medicine Society (DiMe)coreStrategic or Co-development Partner · 9 January 2026Multi-stakeholder initiative 'Scaling Trusted, High-Impact AI Care Navigation' to accelerate responsible AI adoption for patient care management. Stanford Medicine is a founding coalition member alongside Google for Health, Mass General Brigham, and others.
  • OpenAIcoreTechnology or Integration · 8 January 2026Stanford Medicine is an early adopter of OpenAI's HIPAA-compliant healthcare AI suite including ChatGPT for Healthcare and OpenAI API products designed for healthcare organizations requiring compliance with US patient privacy regulations.
  • Epirium BiominorStrategic or Co-development Partner · 27 November 202515-PGDH inhibitor (originally discovered at Stanford) in clinical trials for age-related muscle weakness. Stanford research showed blocking this protein regenerates joint cartilage.
  • CEPIcoreStrategic or Co-development Partner · 6 October 2025Up to $18 million in CEPI funding for Stanford School of Medicine researchers to design AI-powered vaccine constructs using ferritin-based nanoparticle platform for broad protection against filoviruses including Ebola and Marburg.
  • Weill Cornell MedicineminorStrategic or Co-development Partner · 26 September 2025Collaborative study on skin-to-skin contact associated with brain changes in preterm infants, conducted with Burke Neurological Institute and Stanford Medicine.
  • Thrive AI HealthminorStrategic or Co-development Partner · 9 July 2025Research partnership with Stanford Medicine for AI health coaching research focused on sleep, nutrition, fitness, stress management, and social connection to address chronic diseases.
  • Matter NeuroscienceminorStrategic or Co-development Partner · 1 June 2025Clinical collaboration with Stanford Medicine's Psychiatry and Behavioral Sciences Department for controlled study enrolling at least 210 depressed patients using Matter protocol combined with real-time 7T fMRI neurofeedback.
  • Samsung ElectronicscoreTechnology or Integration · 1 April 2025Partnership to enhance sleep apnea management capabilities of Samsung's Galaxy Watch from detection to daily condition management. Stanford Medicine contributing research expertise for sleep apnea AI development.
  • ApplecoreStrategic or Co-development Partner · 1 January 2018Historical collaboration on Apple Heart Study that enrolled over 400,000 participants and led to FDA-cleared ECG feature on Apple Watch. Stanford pioneered research model using consumer wearables with clinical research through opt-in data collection.

Scale indicators20 records

Recent moves9 records

Expansion highlights6 records

Stanford School of Medicine competitors and assessment

Company assessment

Direct peers

  • Johns Hopkins University School of Medicine: Johns Hopkins School of Medicine is a leading US academic medical center with comparable NIH funding, Nobel laureate faculty, and integrated hospital system (Johns Hopkins Hospital). It competes directly with Stanford for research talent, NIH grants, and top medical student candidates.
  • Yale School of Medicine: Yale School of Medicine is a top-tier peer AMC with similar research-education-clinical care structure, comparable NIH funding profile, and direct competition for biomedical research faculty.
  • Duke University School of Medicine: Duke School of Medicine is a peer top-tier US medical school with comparable NIH funding, integrated health system, and similar AI/biomedical research initiatives competing for federal grants and industry partnerships.
  • Harvard Medical School: Harvard Medical School is the most direct peer to Stanford School of Medicine as a top-tier US medical school affiliated with multiple teaching hospitals (Mass General Brigham), with similar tripartite research-education-clinical care mission, comparable NIH funding levels, and overlapping faculty recruitment pools.
  • Washington University School of Medicine in St. Louis: Washington University School of Medicine is a top NIH-funded medical school with comparable research output per faculty member, similar biotech partnership model, and competing for the same faculty and trainee talent.
  • UCSF School of Medicine: UCSF School of Medicine is a top public medical school located in San Francisco with high NIH funding per researcher, similar biotech partnership ecosystem, and overlapping Bay Area patient populations. Competes with Stanford for regional faculty, students, and clinical referrals.
  • Perelman School of Medicine (University of Pennsylvania): Penn's Perelman School of Medicine is a peer top-tier AMC with comparable NIH funding, integrated health system, and AI/biomedical research initiatives. It is also a partner in the Cancer Research Institute Discovery Engine initiative alongside Stanford.
  • Columbia University Vagelos College of Physicians and Surgeons: Columbia's medical school is a peer Ivy League AMC with similar tripartite mission, comparable research funding levels, and overlapping recruitment markets for biomedical research faculty.
  • Weill Cornell Medicine: Weill Cornell Medicine is a peer NYC-based AMC and active research collaborator with Stanford (e.g., Burke Neurological Institute preterm infant study). Comparable in research output, faculty credentials, and integrated hospital system structure.

Broad incumbents

  • Mayo Clinic Alix School of Medicine: Mayo Clinic is a peer integrated academic health system with national reach, comparable clinical excellence, and growing research footprint. Mayo also has a sleep apnea AI collaboration with Stanford. Functions as a broader clinical enterprise rather than Stanford's more research-centric model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Stanford School of Medicine social profiles

Digital presence

Stanford School of Medicine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Stanford School of Medicine leadership team

Management profile

Number of profiles

Profiles14 records

Stanford School of Medicine subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Stanford School of Medicine funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Stanford School of Medicine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stanford School of Medicine

What does Stanford School of Medicine do?

Stanford Medicine operates an integrated academic health system that educates physicians and scientists through MD, MD/PhD, PhD, MS, residency, fellowship, and continuing medical education programs; conducts biomedical research across basic and clinical science departments supported by NIH and other grants; and delivers patient care through Stanford Health Care (adult) and Lucile Packard Children's Hospital Stanford (pediatric and maternal). It also licenses discoveries and runs clinical trials in collaboration with pharmaceutical, biotechnology, and technology partners.

Is Stanford School of Medicine a public or private company?

Stanford School of Medicine is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Stanford School of Medicine founded?

Stanford School of Medicine was founded in 1908. It employs 5,001 to 10,000 people.

Where is Stanford School of Medicine based?

Stanford School of Medicine is headquartered in Stanford, United States, in the North America region.

How does Stanford School of Medicine make money?

Four revenue lines are on record. Research Funding and Grants are the primary driver. The others are clinical Care Services, education and Training and licensing and Royalties.

Who are Stanford School of Medicine's main competitors?

Direct peers on record are Johns Hopkins University School of Medicine, Yale School of Medicine, Duke University School of Medicine, Harvard Medical School, Washington University School of Medicine in St. Louis, UCSF School of Medicine, Perelman School of Medicine (University of Pennsylvania), Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine. Mayo Clinic Alix School of Medicine is listed as a broad incumbent.

Does Stanford School of Medicine have an API?

No public API is recorded for Stanford School of Medicine.

What industry is Stanford School of Medicine in?

Stanford School of Medicine's product category is Academic Medical Center. Its primary akta.pro industry code is EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated), with a secondary code of HLAFAAAA, Academic Medical Centers (AMCs) & Teaching Hospitals. Its NAICS code is 6221 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedicalxpressOne year after taking ibogaine, veterans find continued relief from PTSDStanford Medicine researchers reported that ibogaine therapy provided sustained relief from PTSD, depression, and anxiety in special forces veterans, with remission rates of 84% for PTSD and 66% for depression at one year. The study, published in Translational Psychiatry, found that benefits remained robust for most participants, though the observational design limits causal claims.News-MedicalSimple urine test can accurately diagnose and track bladder cancerResearchers at Stanford Medicine and VA Palo Alto developed a urine test that measures RNA from tumor cells, diagnosing bladder cancer with 95% accuracy in 683 samples. It also predicts which patients will respond to BCG immunotherapy versus chemotherapy, and the study will publish in Nature Medicine.Mirage NewsUrine Test May Improve Bladder Cancer Diagnosis, Guide TreatmentResearchers at Stanford Medicine and VA Palo Alto developed a urine test that measures RNA messages from tumor cells, diagnosing bladder cancer more accurately than standard methods. The test correctly identified 95% of localized cases and predicted BCG treatment response, potentially guiding therapy choices.MedicalxpressRNA urine test outperforms standard bladder cancer tests and could help guide treatmentResearchers at Stanford Medicine and VA Palo Alto developed a urine RNA test that detects bladder cancer more accurately than standard methods. In a study of 683 samples, it correctly identified 95% of localized cases and 90% of non-cases, and predicted treatment response. The test could guide BCG and chemotherapy decisions.News-MedicalBanning ultra-processed foods brings major hurdles for public schoolsA Stanford Medicine study identifies budget constraints, limited staff, procurement difficulties, and inadequate kitchen infrastructure as major hurdles for California schools phasing out ultra-processed foods by 2035. The law requires elimination of certain additives, but less-processed items will strain budgets and require more time and equipment. Researchers urge more funding to support the transition.MedicalxpressCutting ultra-processed food from school menus will be tricky, study suggestsA Stanford Medicine study finds that California schools will face budget, staffing, and infrastructure challenges when phasing out ultra-processed foods by July 2029. The law, AB 1264, requires elimination by 2035, and researchers interviewed 20 districts in the San Joaquin Valley. They recommend more funding and scratch-cooking investments to offset costs.WebProNewsScaling to a Million AI Agents Exposes the Limits of Today’s InfrastructureStanford Medicine assembled a virtual biotech company with up to 37,000 AI agents, cataloging 50,000 trials in under a week. The effort highlights that scaling to millions of agents exposes distributed systems challenges, including latency, coordination complexity, and memory management, which current frameworks rarely address.Ground NewsScientists discover brain is actually two separate organsStanford Medicine researchers published a study in Nature Neuroscience showing the human brain develops from two distinct progenitor cell groups, not a single master cell. The forebrain and hindbrain have separate cellular origins, which could help grow hindbrain neurons in the lab and study ALS and spinal muscular atrophy.The Times of IndiaScientists thought the human brain began as one: New study reveals two ancient cell pathways emerge early, raising a surprising question about how our most complex organ formsA Stanford Medicine study published in Nature Neuroscience found that the human brain develops from two distinct early cell groups, one forming the forebrain and midbrain and the other the hindbrain. The groups differ in gene expression (Otx2 vs Gbx2) and DNA packaging, and the team successfully generated hindbrain motor neurons from human stem cells. This could aid research into neurological diseases like spinal muscular atrophy and ALS.GenengnewsTwo-Organ View of the Human Brain EmergesStanford Medicine researchers found the human brain consists of two distinct organs with separate progenitor cells, overturning the single-origin model. The discovery enables lab-grown hindbrain neurons, aiding research on spinal muscular atrophy and ALS. It also opens avenues for obesity treatment via hunger-regulating circuits.